II. Background: Altitudes
- See FIO2 and PiO2 at Altitude
- Low Altitude: <1500 meters (<4900 feet)
- High Altitude: 1500 to 3500 meters (4900 to 11500 feet)
- Most common elevations for Acute Mountain Sickness: 2500 to 3500 meters (8200 to 11482 feet)
- Affects the greatest number of people exposed who ascend quickly (e.g. travel to alpine city)
- Colorado Ski Resorts: Affects 25% of travelers
- Himalayas: Affects 50% of travelers
- Very High Altitude: 3500 to 5500 meters (11500 to 18000 feet)
- Blood Oxygen Saturation <90% even in health persons
- Associated with severe Acute Mountain Sickness (as well as HACE and HAPE)
- Affects 25% who climb to this altitude
- Extreme Altitude: >5500 meters (>18000 feet)
- Significant Hypoxia and hypercarbia
- Affects 50% who climb above 6000 meters
III. Pathophysiology: Mechanism
- See FIO2 and PiO2 at Altitude
- Oxygen Partial Pressure decreases with altitude related drop in total Ambient air pressure (atmospheric pressure)
- Oxygen maintains its percentage (21%) of overall gas constituents in atmospheric pressure (78% Nitrogen, 1% Argon)
- However, Oxygen Partial Pressure drops in relation to total atmospheric pressure decrease
- DRY Sea level Partial Pressure: 160 mmHg (21% of total atmospheric pressure, 760 mmHg)
- DRY Partial Pressure at 5000 feet: 132 mmHg (21% of total atmospheric pressure, 630 mmHg)
- Partial Pressure is lowered by the humidified, heated air we inspire through our upper airways
- Saturated vapor pressure at Body Temperature (98.6 F or 37 C) is 47 mmHg
- Alveolar Partial Pressure of oxygen at sea level = 0.21 * (760 - 47 mmHg) = 0.21 * 713 = 150 mmHg
- Decreased oxygen Partial Pressure results in fewer oxygen molecules available on inspiration of a given Lung Volume
- Hypoxia risk increases
- Acclimitization to altitude occurs over days to weeks and decreases the risk of High Altitude Illness
- Sleep and Exercise tolerance improve after acclimitization
- Initial response to altitude is hypoxic Ventilatory response
- Increased Respiratory Rate and Minute Ventilation
- Effect is tempered by carbon dioxide levels that fall, resulting in Respiratory Alkalosis
- Respiratory Alkalosis results in decreased respiratory drive
- Respiratory Alkalosis is compensated over 48 hours by increased renal bicarbonate
- Cardiovascular response (Sympathetic Nervous System)
- Increased Heart Rate, venous tone and Cardiac Output
- Pulmonary Hypertension (diffuse pulmonary vessel constriction) results from Hypoxemia response
- Risk of High Altitude Pulmonary Edema (HAPE) in severe Pulmonary Hypertension
- Cerebral Blood Flow results from Hypoxemia response
- Risk of High Altitude Cerebral Edema (HACE) in disordered autoregulation of cerebral Hypertension
- Erythropoietin released from Kidney as a longer-term Hypoxemia response
- Increases Red Blood Cell production and oxygen carrying capacity
- Hypobaric Hypoxemia results in paradoxical and maladaptive physiologic changes at altitude (>1500 meters)
- Hypoxic stress due to lower barometric pressure and less available oxygen (decreased PiO2 and FIOO2)
- Symptom onset may begin within 6-12 hours of ascent
- Fluid retention
- Contrast with non-affected persons at altitude who experience diuresis
- Other Changes at altitude that may exacerbate comorbid illness
- Increased sympathetic tone
- Pulmonary artery Vasoconstriction
- Increased Systemic Vascular Resistance
- Gas expands to take up a greater volume at altitude
- Ambient air pressure (atmospheric pressure) decreases with increasing altitude
- Allows trapped air (e.g. Pneumothorax) to expand
- Example: helicopter transport with 5000 foot rise from sea level
- Results in a pressure drop (14.7 psi to 12.7 psi)
- Results in a Gas Volume increase of 15-20%
- Boyles Law states P1*V1=P2*V2
- Increased sympathetic tone
IV. Types: High Altitude Illness
- Acute Mountain Sickness
- High Altitude Cerebral Edema (HACE)
- High Altitude Pulmonary Edema (HAPE)
V. Risk Factors
- Rapid ascent (as opposed to gradual acclimatization)
- Very high altitude
- Significant physical exertion
- Prior history of altitude sickness
- Traveling from low altitude
- Prolonged time at altitude
- Obesity
-
Genetic susceptibility
- Genetic factors affect a person's ability to acclimatize to altitude
- Younger age
- Aside from comorbidity, older adults may be less affected by altitude
- Substances increasing High Altitude Illness risk (decrease hypoxic Ventilatory response)
VI. Symptoms
- High Altitude Illness or HAI (Acute Mountain Sickness or AMS)
- High Altitude Pulmonary Edema (HAPE)
-
High Altitude Cerebral Edema (HACE)
- Altered Level of Consciousness from confusion and Hallucinations to coma
- Headache
- Photophobia
- Hypertension
- Lassitude
- Truncal Ataxia and inability to ambulate
VII. Course
- Onset: 6-12 hours following high altitude ascent
VIII. Diagnosis
IX. Differential Diagnosis
- Viral illness
- Alcohol Hangover
- Heat Exhaustion
- Dehydration
- Hypothermia
- Hypoglycemia
- Hyponatremia
- Sedative Hypnotic Medications
- Carbon Monoxide Poisoning (e.g. cooking in tent)
- Migraine Headache
X. Complications (0.1 to 4 percent Incidence)
- See Pathophysiology above
- Altitudes above 11,400 feet (3500 meters) are associated with a more complicated course
- High Altitude Pulmonary Edema (HAPE)
- High Altitude Cerebral Edema (HACE)
XI. Management
- Very mild symptoms may resolve spontaneously with acclimitization
- Immediate descent (at least 300 meters or 1000 feet) is most critical for moderate to severe symptoms
- Descent of 500-1000 meters (1640 to 3280) is optimal (typically sufficient in all but the most severe cases)
- Other measures for moderate to severe symptoms where descent is not immediately possible
- Supplemental Oxygen to keep Oxygen Saturation >90%
- Acetazolamide 250 mg orally every 12 hours
- Dexamethasone 8 mg PO/IV/IM loading dose, then 4 mg every 6 hours
- Other measures to consider if descent is delayed and/or Supplemental Oxygen is unavailable
- Nifedipine ER 30 mg every 6 hours
- Phosphodiesterase Inhibitors (Tadalafil)
- Gamow Bag (Portable Hyperbaric Chamber)
- Symptomatic measures
- Antiemetics (e.g. Zofran) for Nausea, Vomiting
- Acetaminophen or Ibuprofen for Headache
XII. Prevention
- Medication Prophylaxis
- Indications
- Travel to 11,000 feet in one day (or over 9,000 feet if history of prior altitude sickness)
- Acetazolamide (Diamox)
- See Acetazolamide for mechanism
- Adults: 125 mg every 12 hours (FDA approved)
- Up to 250 mg twice daily may be used (but 125 mg is typically sufficient)
- Children: 2.5 mg/kg up to 125 mg every 12 hours (off-label)
- Start 1 day or more before ascent
- Continue until acclimitization to the highest sleeping altitude (approximately 2 days)
- Dexamethasone
- Dose: 4 mg orally every 12 hours, or 2 mg every 6 hours (not FDA approved)
- Alternative, in those who cannot take Acetazolamide
- Decreases inflammation, intracerebral pressure (ICP) and Hypoxia-related endothelial dysfunction
- Some Wilderness Medicine experts recommend limiting Dexamethasone for treatment (not prophylaxis)
- Risk of rebound mountain sickness when discontinued
- May require taper with prolonged use (risk of adrenal suppression)
- Does not speed acclimitization, but does reduce symptoms
- Additional mild symptom management (severe symptoms require immediate descent)
- Acetaminophen
- Ibuprofen 600 mg every 8 hours
- May have a prophylactic role (limited evidence)
- Other agents that show promise in studies (but are experimental)
- Nifedipine ER 30 mg every 12 hours starting 24 hours before ascent
- Tadalafil
- Indications
-
General Pointers
- Gradual ascent to allow for acclimitization is the most important single preventive factor
- Recognize the symptoms of Acute Mountain Sickness
- Never ascend to sleep higher if you have symptoms
- Descend if symptoms do not resolve or worsen
- Never leave a person with altitude sickness alone
- Maintain hydration
- Avoid overexertion
- Avoid Alcohol and Sedatives
- For altitudes above 9800 feet (3000 meters)
- Recommended ascent rate <1000 feet/day (300 meter/day)
- Spend an additional rest day if ascent over 2000 feet (600 meters)
- Do not sleep >2000 feet (600 meters) higher than the night before
- Comorbid Conditions
- See Air Travel Restriction
- Patients with asymptomatic cardiopulmonary disease may ascend safely to at least 8200 feet (2500 meters)
- Conditions which absolutely contraindicate high altitude travel
- Severe Chronic Obstructive Pulmonary Disease (COPD)
- Uncontrolled Congestive Heart Failure (CHF)
- Conditions for which caution should be Exercised due to risk of exascerbation (emphasize acclimitization)
- Arrhythmias
- Coronary Artery Disease
- Hypertension
- Sickle Cell Anemia (splenic infarct risk increases above 4900 feet (1500 meters)
- Keep Supplemental Oxygen available
XIII. References
- (2018) Presc Lett 25(2)
- Candy and Contant in Herbert (2020) EM:Rap 20(3): 3-4
- Comp and Rogich (2021) Crit Dec Emerg Med 35(4): 3-8
- Comp and Rogich (2026) Crit Dec Emerg Med 40(9): 29-35
- Basnyat (2003) Lancet 361(9373): 1967-74 [PubMed]
- Fiore (2010) Am Fam Physician 82(9): 1103-10 [PubMed]
- Hackett (2001) N Engl J Med 345(2): 107-14 [PubMed]